Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors

Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogenous group of malignancies originating from neuroendocrine cells of the gastrointestinal tract, the incidence of which has been increasing for several decades. While there has been significant progress in the development of therap...

Full description

Bibliographic Details
Main Authors: Kristen McClellan, Emerson Y. Chen, Adel Kardosh, Charles D. Lopez, Jaydira Del Rivero, Nadine Mallak, Flavio G. Rocha, Yilun Koethe, Rodney Pommier, Erik Mittra, Guillaume J. Pegna
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
gastroenteropancreatic neuroendocrine tumors
resistance
neuroendocrine tumors
peptide receptor radionuclide therapy
somatostatin receptor
targeted therapies
Online Access:https://www.mdpi.com/2072-6694/14/19/4769

Internet

https://www.mdpi.com/2072-6694/14/19/4769

Similar Items